Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
06/11/2024
|
Application #:
|
17052333
|
Filing Dt:
|
11/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/10/2021
| | |
PCT #:
|
US2019031044
|
|
Inventors:
|
Charles R. Allerson, Steven S. Neben, Timothy Wright
|
|
Title:
|
Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 10614 SCIENCE CENTER DRIVE |
| SAN DIEGO, CALIFORNIA 92121 |
|
|
|
|
| MCNEILL BAUR PLLC |
| 125 CAMBRIDGE PARK DRIVE |
| SUITE 301 |
| CAMBRIDGE, MA 02140 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 10614 SCIENCE CENTER DRIVE |
| SAN DIEGO, CALIFORNIA 92121 |
|
|
|
|
| MCNEILL BAUR PLLC |
| 125 CAMBRIDGE PARK DRIVE |
| SUITE 301 |
| CAMBRIDGE, MA 02140 |
|
|
Search Results as of:
05/23/2024 02:44 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
